Gyre Therapeutics
GYRE
#5535
Rank
S$1.35 B
Marketcap
$15.81
Share price
-8.99%
Change (1 day)
-7.16%
Change (1 year)

Gyre Therapeutics (GYRE) - P/B ratio

P/B ratio as of November 2024 : 10.8

According to Gyre Therapeutics's latest financial reports the company has a price-to-book ratio of 11.8144.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Gyre Therapeutics - P/B ratio (from 2024 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-31140